期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童全身^(18)F-FDG PET/CT辐射剂量评估 被引量：6

Evaluation of Radiation Dose in Pediatric Whole-Body Dual-Modality ^(18)F-FDG PET/CT Examinations
下载PDF
导出
摘要 目的:研究和评估受检儿童在全身PET/CT显像中所受到的辐射剂量,并讨论其可能受到的辐射损伤。方法:选取60例接受全身PET/CT显像儿童患者(<18岁),在自动曝光技术下通过公式估算出CT和PET的全身有效剂量值,将估算结果与国外类似报道结果比较。结果:单次PET/CT显像,受检儿童所受CT有效剂量为(2.8～10.8)mSv,平均(5.9±1.8)mSv;PET有效剂量为(4.5～12.4)mSv,平均(7.2±2.0)mSv;PET/CT总有效剂量为(8.55～20.2)mSv,平均(13.1±2.9)mSv;CT有效剂量占总有效剂量比例为45.2%;年龄越大,CT所导致的辐射剂量也越大;自动曝光技术下儿童全身PET/CT辐射剂量明显低于固定能量PET/CT扫描。结论:配备有AEC技术的PET/CT单次检查所致辐射剂量对受检儿童来说是安全的。 Objective To evaluate the radiation dose of children patient in whole-body dual-modality 18F-FDG PET/CT examinations and discuss the possibility of radiation damage.Methods PET/CT studies on 60 children and teen-age youths patient（〈18y） were retrospectively reviewed.The effective dose of PET/CT was the summation of CT and PET dosimetry estimated by the conversion formula with automatic exposure control（AEC） technique.Result The mean dose of an individual CT study was 5.9±1.8mSv（range： 2.8 to 10.8 mSv）,of PET study was 7.2±2.0mSv（range： 4.5to 12.4 mSv） and of PET/CT study was 13.1±2.9mSv（range： 8.5 to 20.2 mSv）.The proportion of dose due to CT scan is 45.2%.The effective dose due to CT scan ascend with age.Divice equipped with AEC technique can provide lower dose than fixed energe divice significantly.Conclusion Individual whole-body dual-modality 18F-FDG PET/CT examination equipped with AEC technique provides safety for children.
作者 吴震宇 王辉
机构地区 上海交通大学医学院附属新华医院核医学科
出处 《放射免疫学杂志》 CAS 2012年第5期494-497,共4页 Journal of Radioimmanology
关键词 儿童 正电子发射型计算机断层显像 有效剂量 辐射 自动曝光技术 children position emmission tomography（PET） effective dose radiation AEC technique
分类号 R739.41 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1Peoppel TD, Krause BJ,Heusner TA, et al. PET/CT for the staging and follow-up of patients with malignancies [ J]. European Journal of Radiology, 2009,70,3:382-392.
  • 2Federman N, Feig SA. PET/CT in the evaluating pediatric malignancies: a clinician's perspective [ J ]. J Nucl Med,2007,48 : 1920-1922.
  • 3Kumar R, Shandal V, Shamim SA, et al. Clinical applications of PET and PET/CT in pediatric malignancies [ J ]. Expert Rev Anticancer Ther,2010, 10(5) :755-768.
  • 4Michael J, Gelfandl, Marguerite T, et al. Pediatric radiopharmaceutical administered doses: 2010 North American Consensus Guidelines [J]. The Journal of Nuclear Medicine, 2011, 52(2) :318-322.
  • 5McNitt-Gray. AAPM/RSNA Physics Tutorial for Residents : Topics in CT. Radiation dose in CT [ J ]. Radiographies, 2002, 22 ( 6 ) : 1541-1553.
  • 6CEC Quality criteria for computed tomography, European guidelines, EUR 16262[ M]. Luxembourg Commission of the European Communities, 1999:70.
  • 7Khursheed A, Hillier MC, Shrimpton PC, et al. Influence of patient age on normalized effective doses calculated for CT examinations [ J]. Br J Radiol,2002,75:819-830.
  • 8Valentin J. Radiation dose to patients from radiopharmaceuticals ( addendum 2 to ICRP publication 53 ) ICRP publication 80 approved by the Commission in September 1997 [ J ]. Ann ICRP, 1998,28 : 1.
  • 9Chawla SC, Federman N, Zhang D, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review [ J ]. Pediatr Radiol, 2010, 40 ( 5 ) : 681-686.
  • 10Alessio AM, Kinahan PE, Manchanda V,et al. Weight-based, low-dose podiatric whole-body PET/CT protocols [ J ]. J Nucl MOd,2009, 50(10) : 1570-1577.

二级参考文献7

  • 1[1]Brenner DJ,Hall FJ.Computed Tomography-an increasing source of radiation exposure[J].New England Journal of Medicine,2007,357:2277-84.
  • 2[2]Daniel Gutierreza,Sabine Schinidtb,Albau Denysb,et al.CT-automatic exposure control devices:What are their performances[J].Nuclear Instruments and Methods in Physics Research A,2007,580:990-995.
  • 3[3]Hongyu Jiang,Harald Paganetti,Herman Suit.A Case Study on Patient Effective Doses during Proton Racliation Treatment[A].American Nuclear Society,2005,4:17-21.
  • 4[4]S.HEINRICH,A.KELLEP.Quasi-Monte Carlo methods in computer graphics,Part Ⅱ:The Radiance Equation[R].Technical Report,University of Kaiserslautem,1994,94:243-246.
  • 5[5]Mathias Cohnen,Ludger W.Poll,Claudia Puettmann.Effective dose in standard protocols for multi-slice CT scanning[J].Eur Radiol,2003,13:1148-1153.
  • 6[6]1990 Recommendations of the International Commission on Radiological Protection,Annals of the ICRP 1991[S].ICRP Publication NO.60.Vol.21(1):17-37.
  • 7白玫.CT设备剂量指数(CTDI)的计算机数据处理[J].医疗设备信息,2001,16(2):19-21. 被引量：3

同被引文献76

  • 1贺小红.^(18)F-FDG正电子显像质量保证[J].国外医学（放射医学核医学分册）,2004,28(5):193-196. 被引量：8
  • 2朱家瑞,Lumbroso J,Hartmann O,Parmentier C.^(123)I-间碘苄胍显像对儿童神经母细胞瘤诊断和分期的临床价值[J].中国医学影像学杂志,1995,3(2):102-105. 被引量：1
  • 3孙洁,汤静燕.儿童肾母细胞瘤的诊断治疗进展[J].中国小儿血液与肿瘤杂志,2007,12(1):41-45. 被引量：9
  • 4Kleis M, Daldrup-Link H, Matthay K, et al. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors[ J]. Eur J Nucl Med Mol Imaging, 2009, 36(1) : 23 -36.
  • 5Lemerle J, Vo~e PA, Tournade MF, et al. Preoperative versus post- operative radiotherapy, single versus multiple courses of Actinomycin D, in the treatment of Wilms tumor, Preliminary results of a con- trolled clinical trial conducted by the International Society of Pediatric Oncology (SLOP)[J]. Cancer, 1976, 38(2): 647-654.
  • 6Weirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity[J]. Ann Oncol, 2004, 15(5) : 808 -820.
  • 7Moinul Hossain AK, Shulkin BL, Gelfand M J, et al. FDG positron emission tomography/computed tomography studies of Wilms' tumor [J]. Eur J Nucl Med MolImaging, 2010, 37(7): 1300-1308.
  • 8Misch D, Steffen IG, Schonberger S, et al. Use of positron emission tomography for staging, preoperative response assessment and postt- herapeutic evaluation in children with Wilms tumour[ J]. Eur J Nucl Med Mol imaging, 2008, 55 (9) : 1642 - 1650.
  • 9Begent J, Sebire NJ, Levitt G, et al. Pilot study of F(18)-Fluoro- deoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: Correlation with conventional imaging, pathology and immunohistochemistry[ J]. Eur J Cancer, 2011, 47 (3): 389-396.
  • 10Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol, 1993, 11(8): 1466-1477.

引证文献6

二级引证文献20

放射免疫学杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部